EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reduced Survival Outcomes in Socioeconomically Disadvantaged Women with HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada

Danilo Giffoni M M Mata, Italo Fernandes, Megan Smith-Uffen, Claire Browne, Raman Sambhi, Sara Gehlaut, Rossanna C Pezo, Kelvin K W Chan, Ines Menjak, Andrea Eisen, Maureen Trudeau

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2026.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Danilo Giffoni M M Mata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Verspeeten Family Cancer Centre, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine an…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleErb-b2 Receptor Tyrosine KinasesRetrospective StudiesMiddle AgedAgedOntarioLow Socioeconomic StatusSocioeconomic Disparities in HealthAdultChemotherapy, AdjuvantSurvival RateFollow-Up StudiesNeoplasm Staging

Stichwörter der Autor:innen

DisparitiesExclusionInequitiesOntarioUnderrepresented

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Division of Medical Oncology, Verspeeten Family Cancer Centre, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; ICES Western…
  • Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Medical Oncology, Verspeeten Family Cancer Centre, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Cancer Program, ICES, Toronto, On…
  • Division of Medical Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Zitieren

APA

Giffoni M M Mata, D., Fernandes, I., Smith-Uffen, M., Browne, C., Sambhi, R., Gehlaut, S., Pezo, R. C., Chan, K. K. W., Menjak, I., Eisen, A., & Trudeau, M. (2026). Reduced Survival Outcomes in Socioeconomically Disadvantaged Women with HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.02.015

Vancouver

Giffoni M M Mata D, Fernandes I, Smith-Uffen M, Browne C, Sambhi R, Gehlaut S, et al. Reduced Survival Outcomes in Socioeconomically Disadvantaged Women with HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.02.015

BibTeX
@article{GiffoniMMMata2026,
  author = {Giffoni M M Mata, Danilo and Fernandes, Italo and Smith-Uffen, Megan and Browne, Claire and Sambhi, Raman and Gehlaut, Sara and Pezo, Rossanna C and Chan, Kelvin K W and Menjak, Ines and Eisen, Andrea and Trudeau, Maureen},
  title = {Reduced Survival Outcomes in Socioeconomically Disadvantaged Women with HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2026.02.015}
}
Kostenlos starten →